Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121029613 | 12102961 | 3 | F | 20131101 | 20160823 | 20160222 | 20160826 | PER | US-CELGENEUS-USA-2016024163 | CELGENE | 71.18 | YR | F | Y | 69.92000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121029613 | 12102961 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A0586B | 21880 | 25 | MG | CAPSULES | QD | ||||
| 121029613 | 12102961 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | Y | U | A0586B | 21880 | 5 | MG | CAPSULES | |||||
| 121029613 | 12102961 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | U | 0 | UNKNOWN | ||||||||
| 121029613 | 12102961 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 6 | C | Warfarin | WARFARIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 7 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 9 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121029613 | 12102961 | 10 | C | Calcium | CALCIUM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121029613 | 12102961 | 1 | Plasma cell myeloma |
| 121029613 | 12102961 | 3 | Product used for unknown indication |
| 121029613 | 12102961 | 4 | Product used for unknown indication |
| 121029613 | 12102961 | 5 | Product used for unknown indication |
| 121029613 | 12102961 | 6 | Product used for unknown indication |
| 121029613 | 12102961 | 7 | Product used for unknown indication |
| 121029613 | 12102961 | 8 | Product used for unknown indication |
| 121029613 | 12102961 | 9 | Product used for unknown indication |
| 121029613 | 12102961 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121029613 | 12102961 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121029613 | 12102961 | Neuropathy peripheral | |
| 121029613 | 12102961 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121029613 | 12102961 | 1 | 20130909 | 0 | ||
| 121029613 | 12102961 | 2 | 201407 | 0 |